Notably, besides inhibiting tumor vasculature growth, VEGFR inhibitors have a direct anti-tumor effect, interfering with cancer cell survival [218], and can also induce vessel normalization [219], thereby improving the blood flow and providing effective delivery of anti-cancer agents to solid tumors. This evidence concerns the gene KDR and neoplasm.